Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.85 USD | -2.25% | +2.36% | +19.23% |
May. 13 | Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.23% | 11.48M | |
+42.53% | 54.04B | |
+43.57% | 41.96B | |
-1.38% | 41.92B | |
-7.59% | 28.35B | |
+11.66% | 26.35B | |
-22.02% | 19B | |
+7.59% | 13B | |
+28.43% | 12.28B | |
+25.64% | 12.19B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Avalo Says Trial of AVTX-002 to Treat Non-Eosinophilic Asthma Did Not Meet Primary Endpoint; Shares Slump